There is a question that arrives for almost everyone, usually somewhere around the point the weight has come off and life has settled into something steadier. Do I have to stay on this forever? It is asked with a mix of things underneath it: the cost, the slight unease about being on a medication long-term, the quiet hope that the hard part is done and the body will now simply hold its new shape on its own. It is a completely reasonable question. It deserves a complete answer rather than either a cheerful “you’ll be fine” or a grim “you’re on this for life.”
The honest place to start is not with the medication at all. It is with why the weight was there in the first place, and why it came off, because that is the thing that determines what happens when you stop.
Why this conversation has to start at the start
For decades the story told about weight was a simple and quietly cruel one: eat less, move more, and if it is not working you are not trying hard enough. Most people reading this have lived inside that story. They have done the diets, lost the weight, watched it come back, and concluded the failure was theirs. It was not. The reason that cycle repeats is not weak character, it is biology doing exactly what it evolved to do.
When the body loses a meaningful amount of weight, it does not interpret that as success. It interprets it as a threat. A whole set of compensatory changes switches on to push the weight back up: appetite hormones increase, the sense of fullness after eating weakens, and the metabolism runs a little leaner than you would predict for the new body size. This is not a moral failing dressed up as physiology. It is a measured, repeatable biological response to weight loss, and it is the single biggest reason that keeping weight off has always been harder than taking it off.
This is also why the medical understanding of obesity has shifted. It is now treated by clinical bodies as a chronic condition, one with a strong biological basis, rather than a lifestyle that can be corrected once and filed away. That reframing matters here, because it changes the entire shape of the “forever” question. We do not ask whether someone with high blood pressure can stop their medication once their reading is normal and simply expect the number to stay down on its own. The medication is managing an ongoing condition, not curing a temporary one. GLP-1 medications, for many people, sit in the same category.
At Anova we think this is the part that gets skipped, and skipping it is what makes the stopping conversation so loaded. If you believe the weight loss “fixed” something, then needing to continue feels like failure. If you understand that you are managing a persistent biological set-point, then continuing, or tapering carefully, or stopping with eyes open, are simply different management choices, none of which is a verdict on you.
What the trials actually show when people stop
Here the evidence is genuinely clear, and it is worth knowing the real numbers rather than a vague sense of “you might put some back on.”
In the extension of one of the largest trials of these medications, people stopped treatment after 68 weeks. Over the following year, they regained about two-thirds of the weight they had lost. Having lost an average of around 17% of body weight on treatment, a year after stopping they were holding roughly 5 to 6% below where they started. The weight came back gradually rather than overnight, and importantly, the improvements in things like blood pressure and blood sugar that came with the weight loss faded as the weight returned.
The picture with the newer combination-action medications is similar in direction. In withdrawal trials, people who stopped and switched to placebo regained a large share of their loss over the following year, while those who continued not only held their loss but tended to lose a little more. A more recent analysis put it starkly: among those who stopped, the large majority had regained at least a quarter of their lost weight within a year.
It would be easy to read those numbers as a warning bell, and that is precisely the reading we want to avoid. The point is not “if you stop you will balloon back and it was all for nothing.” That is both inaccurate and the kind of fear-based framing that helps no one. The point is the opposite and more useful: the regain is not a sign that you did something wrong, it is the predictable return of the underlying biology the medication was managing. The set-point did not disappear during treatment, it was held down. Remove what was holding it, and it does what it was always going to do. Knowing that in advance turns a frightening surprise into a manageable, expected variable you can plan around.
Stopping is not the only door
Most of the public conversation treats this as binary: you are either on the full medication or you are off it entirely. The clinical reality has more doors than that, and the middle options are where a lot of the interesting recent evidence sits.
The maintenance dose. For many people, staying on the medication does not mean staying on the full dose used to lose the weight. Once you reach a weight you are content with, the conversation with your prescriber often turns to finding the lowest dose that holds the result. The dose that takes weight off and the dose that keeps it off are not always the same, and a lower maintenance dose can mean fewer side effects and lower cost while still doing the job. Recent trials have started to test exactly this, and early results suggest a reduced maintenance dose preserves much of the weight loss far better than stopping outright.
Tapering rather than stopping abruptly. Where someone does want to come off, doing it gradually, stepping the dose down over weeks or months while deliberately reinforcing eating, movement and sleep habits, appears to give a gentler ride than stopping suddenly. The evidence here is still thin and we should be honest about that, but the practical logic is sound: a slow withdrawal gives the appetite system time to adjust and gives you time to notice and respond to early changes rather than being caught out.
On-and-off and less-frequent dosing. Some people, often driven by cost or supply, have extended the gap between doses or paused for periods. The structured evidence for this is limited and it is not a strategy to improvise alone, because the regain biology does not pause politely between doses. But it is an area of active clinical interest, and for some people a less-frequent regimen under proper supervision may turn out to be a viable middle path. The key phrase is “under proper supervision.” This is a conversation to have with a prescriber, not an experiment to run by yourself.
What unites all three is that they are decisions made with a clinician who knows your history, not rules that apply to everyone. The right answer for a person who reached their goal comfortably and has rock-solid habits is different from the answer for someone who fought for every kilogram and whose appetite roared back the moment the dose dropped. That is the whole point of managing a chronic condition rather than following a one-size script.
What sensible looks like in practice
If you are turning this question over, a few principles hold up well across the evidence.
Decide what you are optimising for. Lowest possible long-term cost, fewest medications, best chance of holding the weight, fewest side effects, these can pull in different directions, and naming your priority makes the conversation with your prescriber far more productive.
Do not stop on a whim or in a gap. The most avoidable version of regain is the one that happens when someone stops abruptly, without a plan, and without the habit scaffolding in place to soften the landing. If you are going to come off, come off deliberately.
Treat your habits as the thing that does the heavy lifting when the dose comes down. The medication makes the eating and movement changes easier to sustain by quietening appetite. As its support reduces, those habits carry more of the load. The people who do best on a lower dose, a taper, or a stop are generally the ones who used the time on full dose to build patterns that hold up on their own.
Keep monitoring after any change. Weight, and the metabolic markers underneath it, drift gradually rather than jumping. Regular check-ins mean a change of direction is caught early, while it is still small and easy to respond to, which is exactly the kind of ongoing visibility a coordinated program is built to provide.
A note on cost, and where this is heading
It would be dishonest to discuss “forever” without naming the thing sitting underneath a lot of these decisions, which is cost. For many people the question is not purely clinical, it is whether indefinite treatment is affordable, and that is a legitimate part of the decision rather than a separate matter to be embarrassed about. It is also why the maintenance-dose and lower-cost-pathway research matters so much: the most equitable version of this care is one where the heavy treatment is available to get the weight off, and a lighter, cheaper option is available to keep it off.
There is a larger version of this question, about how these medications are funded and regulated, and whether the system should treat long-term obesity medication the way it treats other chronic-disease medication. That is a real and active debate, and it deserves its own piece rather than a paragraph here. For now, the practical message is that cost is a fair thing to weigh, worth raising openly with your prescriber, and increasingly something the emerging lower-dose options are designed to address.
The thing worth holding onto
“Do I have to stay on this forever?” turns out to be the wrong shape of question. The better one is: how do I manage this condition over the long term, in a way that fits my body, my goals and my life? Sometimes the answer is staying on a maintenance dose. Sometimes it is a careful taper. Sometimes, for some people with the right circumstances and support, it is coming off and holding the line with habits and monitoring. None of these is a pass or a fail.
What the evidence rules out is only the fantasy version, the idea that the weight loss permanently resets the body and the medication can simply be dropped with no plan and no consequence. Letting go of that fantasy is not bad news. It is what lets you make a real decision, with real numbers, instead of being blindsided later.
If you are weighing this up, it is a conversation worth having with someone who knows your history, at Anova or with your own GP, rather than a decision made alone or deferred until something forces it.